This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Illinois. Active years: 2018-2021.
Company Filing History:
Years Active: 2018-2021
Title: Michael Kierny: Innovator in High Affinity Binding Agents
Introduction
Michael Kierny is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of binding agents, holding 2 patents that showcase his innovative methods. His work primarily focuses on developing techniques that enhance the identification and generation of high affinity binding agents.
Latest Patents
Kierny's latest patents include a method and kit for generating high affinity binding agents. This combined ribosome-display and phage-display method provides a systematic approach to screening a ribosome-display library of binding agents. The process identifies binding agents that interact with specific target molecules of interest. It involves converting the RNA encoding the binding agents into a phage-display format through amplification and primer extension. The phage-display library is then screened to enrich for binding agents that effectively interact with the target molecules.
Career Highlights
Michael Kierny is affiliated with the University of Illinois, where he continues to advance his research and innovation in binding agents. His work has garnered attention for its potential applications in various scientific fields, particularly in biochemistry and molecular biology.
Collaborations
Kierny collaborates with Brian Kay, a fellow researcher, to further explore the applications of their innovative methods in generating high affinity binding agents.
Conclusion
Michael Kierny's contributions to the field of binding agents through his innovative patents and collaborative efforts highlight his role as a significant inventor. His work continues to pave the way for advancements in the identification and application of binding agents.